Atrial natriuretic peptide, cyclic GMP analogues and modulation of guanylyl cyclase do not alter stimulated POMC peptide release from perifused rat or sheep corticotrophs

Journal of Neuroendocrinology

Volumn 9, Issue 12, 1997, Pages 929-936

  Bowman, Maria E ^a   Robinson, Phillip J ^a   Smith, Roger ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

ACTH release; ANP; Anterior pituitary; cGMP; Corticotroph; Nitric oxide; POMC; Secretion; EP release

Indexed keywords

8 BROMO CYCLIC GMP; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC GMP DERIVATIVE; DEXAMETHASONE; DIBUTYRYL CYCLIC GMP; GUANYLATE CYCLASE; MOLSIDOMINE; PEPTIDE; PROOPIOMELANOCORTIN; SODIUM NITRITE;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; ENZYME MODIFICATION; HYPOPHYSIS CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; SHEEP; SIGNAL TRANSDUCTION;

EID: 0031459793     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1997.00665.x     Document Type: Article

References (44)

1. Engler D, Pham T, Liu J, Fullerton MJ, Clarke IJ, Funder JW. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. II. Evidence for in vitro ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary. Endocrinology 1990; 127: 1956-1965.
2. Waldmann SA, Rapoport RM, Murad F. Atrial natriuretic factor selectively activates paniculate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem 1984; 259: 14332-14334.
3. Shibasaki T, Naruse M, Yamauchi N, Masuda A, Imaki T, Naruse K, Demura H, Ling N, Inagami T, Shizume K. Rat atrial natriuretic factor suppresses proopiomelanocortin-derived peptides secretion from both anterior and intermediate lobe cells and growth hormone release from anterior lobe cells of rat pituitary in vitro. Biochem Biophys Res Commun 1986; 135: 1035-1041.
4. King MS, Baertschi AJ, Physiological concentrations of atrial natriuretic factors with intact N-terminal sequences inhibit corticotropin-releasing factor-stimulated adrenocorticotropin secretion from cultured anterior pituitary cells. Endocrinology 1989; 124: 286-292.
5. Dayanithi G, Antoni FA. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. Endocrinology 1989; 125: 308-313.
6. Dayanithi G, Antoni FA. Atriopeptins are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vitro: involvement of the atrial natriuretic factor receptor domain of membrane-bound guanylyl cyclase. J Endocrinol 1990; 125: 39-44.
7. Dayanithi G, Antoni FA. Secretion of ACTH by perifused isolated rat anterior pituitary cells: pulses of secretagogue enhance the secretory response and modify the effect of atriopeptin. J Endocrinol 1990; 125: 365-373.
8. Heisler S, Simard J, Assayag E, Mehri Y, Labrie F. Atrial natriuretic factor does not affect basal, forskolin-and CRF-stimulated adenylate cyclase activity, cAMP formation or ACTH secretion, but does stimulate cGMP synthesis in anterior pituitary. Mol Cell Endocrinol 1986; 44: 125-131.
9. Horvath J, Ertl T, Serially AV. Effect of atrial natriuretic peptide on gonadotropin release in superfused rat pituitary cells. Proc Natl Acad Sci USA 1986; 83: 3444-3446.
10. Abou-Samra AB, Catt KJ, Aguilera G. Synthetic atrial natriuretic factors (ANFs) stimulate guanine 3′,5′-monophosphate production but not hormone release in rat pituitary cells: peptide contamination with a gonadotropin-releasing hormone agonist explains luteinizing hormone-releasing activity of certain ANFs. Endocrinology 1987; 120: 18-24.
11. Hashimoto K, Hattori T, Suemaru S, Sugawara M, Takao T, Kageyama J, Ota Z. Atrial natriuretic peptide does not affect corticotropin-releasing factor-, arginine vasopressin-and angiotensin II-induced adrenocorticotropic hormone release in vivo or in vitro. Regul Pept 1987; 17: 53-60.
12. Koch B, Lutz-Bucher B. Indirect relationship between vasopressin-induced secretion of ACTH and cyclic nucleotides in cultured anterior pituitary cells. Eur J Pharmacol 1989; 158: 53-60.
13. Mulligan RS, Livesey JH, Evans MJ, Ellis MJ, Donald RA. Atrial natriuretic and C-type natriuretic peptide do not acutely inhibit the release of adrenocorticotropin from equine pituitary cells in vitro. Neuroendocrinology 1997; 65: 64-69.
14. Antoni FA, Dayanithi G. Guanosine 3′:5′cyclic monophosphate and activators of guanylate cyclase inhibit secretagogue-induced corticotropin release by rat anterior pituitary cells. Biochem Biophys Res Commun 1989; 58: 824-830.
15. White RE, Lee AB, Shcherbatko AD, Lincoln TM, Schonbrunn A, Armstrong DL. Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature 1993; 361: 263-266.
16. Tan TT, Yang Z, Huang W, Lim AT. ANF(1-28) is a potent suppressor of pro-opiomelanocortin (POMC) mRNA but a weak inhibitor of βEP-LI release from AtT-20 cells. J Endocrinol 1994; 143: R1-4.
17. Li H, Liu J-P, Smith R, Robinson PJ. Identification of cGMP-dependent protein kinase activity and specific substrates in the anterior pituitary. Mol Cell Endocrinol 1996; 122: 159-171.
18. Antoni FA, Dayanithi G. Evidence for distinct glucocorticoid and guanine 3′,5′-monophosphate-effected inhibition of stimulated adrenocorticotropin release in vitro. Endocrinology 1990; 126: 1355-1360.
19. Rivier CL, Plotsky PM. Mediation by corticotrophin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Biochem 1986; 48: 475-494.
20. Schwartz J, Vale W. Dissociation of the adrenocorticotropin secretory responses to corticotropin-releasing factor (CRF) and vasopressin or oxytocin by using specific cytotoxic analog of CRF. Endocrinology 1988; 122: 1695-1700.
21. Familari M, Smith AI, Smith R, Funder JW. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. Neuroendocrinology 1989; 50: 152-157.
22. Liu JP, Robinson PJ, Funder JW, Engler D. The biosynthesis and secretion of adrenocorticotropin by the ovine anterior pituitary is predominantly regulated by arginine vasopressin (AVP). Evidence that protein kinase C mediates the action of AVP. J Biol Chem 1990; 265: 14136-14142.
23. Liu J-P. Studies of the mechanisms of action of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) in the ovine anterior pituitary: evidence that CRF and AVP stimulate protein phosphorylation and dephosphorylation. Mol Cell Endocrinol 1994; 106: 57-66.
24. Evans MJ, Brett JT, McIntosh RP, McIntosh JEA, McLay JL, Livesey H, Donald RA. Characteristics of the ACTH response to repeated pulses of corticotrophin-releasing factor and arginine vasopressin in vitro. J Endocrinol 1988; 117: 387-395.
25. Labrie F, Veilleux R, Lefevre G. Corticotrophin-releasing factor stimulates accumulation of adenosine 3′,5′-monophosphate in rat pituitary corticotrophs. Science 1982; 216: 1007-1008.
26. Litvin Y, Pasmantier R, Fleischer N, Erlichman J. Hormonal activation of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by corticotropin releasing factor, isoproterenol, and forskolin. J Biol Chem 1984; 259: 10296-10302.
27. Raymond V, Leung PCK, Veilleux R, Labrie F. Vasopressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells. FEBS Lett 1985; 182: 196-200.
28. Todd K, Lightman SL. Vasopressin activation of phosphatidylinositol metabolism in rat anterior pituitary in v̇itro and its modification by changes in the hypothalamo-pituitary-adrenal axis. Neuroendocrinology 1987; 45: 212-218.
29. Clarke IJ, Clements JA, Cummins JT, Dench F, Smith AI, Robinson PM, Funder JW. Elevated plasma levels of pro-opiomelanocortin-derived peptides in sheep following hypothalamo-pituitary disconnection. Neuroendocrinology 1986; 44: 508-514.
30. Ishibashi M, Yamaji T. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro. J Clin Invest 1981; 68: 1018-1027.
31. Nicholson SA, Adrian TE, Gillham B, Jones MT, Bloom SR. Effect of hypothalamic neuropeptides on corticotrophin release from quarters of rat anterior pituitary gland in vitro. J Endocrinol 1984; 100: 219-226.
32. Redei E, Evans C. Dual control of corticotropin secretion: Isolation of corticotropin-inhibiting factor. In: Tache Y, Morley JE, Brown MR, eds. Neuropeptides and Stress. New York: Springer-Verlag, 1989: 61-71.
33. Chinkers M, Garbers DL, Chang M. Lowe DG, Chin H, Goeddel DV, Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989; 338: 78-83.
34. Palkovits M, Eskay RL, Antoni FA. Atrial natriuretic peptide in the median eminence is of paraventricular nucleus origin. Neuroendocrinology 1987; 46: 542-544.
35. Gilkes AF, MacKay KB, Cramb G, Guild SB. Atrial-natriuretic peptide effects in AtT-20 pituitary tumour cells. Mol Cell Endocrinol 1992; 89: 39-45.
36. Ur E, Faria M, Tsagarakis S, Anderson JV, Besser GM, Grossman A. Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects. J Endocrinol 1991; 131: 163-167.
37. Kellner M, Weidemann K, Holsboer F. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 1992; 50: 1835-1842.
38. Januszewicz P, Thibault G, Garcia R, Gutkowska J, Genest J, Cantin M. Effect of synthetic atrial natriuretic factor on arginine vasopressin release by the rat hypothalamo-neurohypophysial complex in organ culture. Biochem Biophys Res Commun 1986; 134: 652-658.
39. Ibanez-Santos J, Tsagarakis S, Rees LH, Besser GM, Grossman A. Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro. J Endocrinol 1990; 126: 223-228.
40. Jia LG, Canny BJ, Leong DA. Paracrine communication regulates adrenocorticotropin secretion. Endocrinology 1992; 130: 534-539.
41. McFarlane AC, Wintour EM. Effect of atrial natriuretic factor on corticotrophin-releasing hormone-induced adrenocorticotrophin release in the mature ovine foetus. Clin Exp Pharmacol Physiol 1996; 23:428-431.
42. Redei E, Hilderbrand H, Aird F. Corticotropin release inhibing factor is encoded within prepro-TRH. Endocrinology 1995; 136: 1813-1816.
43. Redei E, Hilderbrand H, Aird F. Corticotropin release-inhibiting factor is preprothyrotropin-releasing hormone-(178-199). Endocrinology 1995; 136: 3557-3563.
44. Nicholson WE, Orth DN. Preprothyrotropin-releasing hormone-(178-199) does not inhibit corticotropin release. Endocrinology 1996; 137: 2171-2174.